(Q39335039)

English

Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

3

object named as

Andrzej Emeryk

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Teresa Bracamonte

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Uwe Schauer

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Alex Godwood

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sima Balsara

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1-11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

British guideline on the management of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trials to assess equivalence: the importance of rigorous methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical effect of Diskus ™ dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aerosol delivery systems in childhood asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol/Fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spacer devices for metered dose inhalers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200525010-00001

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39335039&oldid=1820614079"